premenstrual syndrome and premenstrual dysphoric disorder Flashcards
(9 cards)
A 34 yo patient reports a history of emotional lability, crying, irritability and anger one to two weeks prior to menses for about six months. She denies difficulty at work or at home when she is not premenstrual.
You ask the patient to keep a symptom diary for two or three cycles. When the patient returns, her diary reflects a likely diagnosis of premenstrual syndrome. You counsel her about the disorder and offer her treatment with fluoxetine for two weeks prior to menses. The patient begins treatment and notices that her symptoms improve.
Premenstrual syndrome (PMS)
-Changes in physical and mental well-being in cyclical manner and related to luteal phase
-80% of pts
-May present at any time
-Increased risk among twins
-Etiology
-Unknown
-May involve physiologic hormonal changes due to ovarian cycles
-Possibly due to changes in serotonin due to cyclic hormonal fluctuation
-Less serotonin available in luteal phases due to effects of estrogen and progesterone
premenstrual syndrome: sx
-abdominal bloating
-fatigue
-mastodynia
-H/A
-acne
-GI upset
-dizziness
-Common mental sx:
-Anxiety
-Depressed mood
-Irritability
-Sadness
-Hostility
-Increased appetite
-Difficulty in concentration
-Changes in libido
dx criteria of premenstrual syndrome
-at least 1 of following affective and somatic sx during the 5 days before menses in 3 menstrual cycles
-Sx relieved within 4 days of onset of menses
-Sx do not recur until cycle day 13
-identifiable dysfunction in social or economic performance
-Somatic sx:
-Mastalgia
-Abdominal bloating
-Headache
-Swelling of extremities
-Weight gain
-Joint or muscle pain
-Affective sx:
-Depression
-Angry outbursts
-Irritability
-Anxiety
-Confusion
-Social withdrawal
-Symptom diary documenting defining symptoms as noted above for at least 2 consecutive menstrual cycles
-Document all symptoms that occur as well as onset of bleeding and when symptoms abate
-Also have the patient monitor severity of symptoms
PMS diff dx
-breast disorders
-chronic fatigue
-anemia
-lyme ds
-connective tissue disorders
-substance abuse
-endocrinologic disorders
-Cushing’s syndrome and hypoadrenalism
-Thyroid disorders
-Stress
-Gastrointestinal conditions
-Irritable bowel disease
-Pelvic inflammatory disease
management of PMS
-Dietary and lifestyle changes
-fresh fruits and vegetables
-Minimize refined sugars, fats
-Decreased alcohol consumption
-Smoking cessation
-Increased aerobic exercise
-Calcium supplementation
-Vitamin B6 and vitamin E supplementation
-Other alternative therapies (yoga, acupuncture, etc.) may be of benefit (or not)
-Additional tx:
-Spironolactone for fluid retention
-Bromocriptine for mastalgia
-NSAIDs for physical symptoms
-Oral contraceptives- Consider strongly using an extended cycle OC
-Danazol
-GnRH agonists
management of severe sx
-SSRIs
-May be used continuously or only during the luteal phase
-Sertraline
-Paroxetine
-Atypical antipsychotics to be used continuously for 3 menstrual cycles
-Oral contraceptives (esp. extended cycle OCs)
premenstrual dysphoric disorder (PMDD)
-<5% of women of reproductive age
-at any time in reproductive life
-more significant than PMS
-similar or identical to sx to PMS however ->
-In most cycles in past year, ≥5 of the following in last week of luteal phase, improved within a few days of menses, and were absent in first week after menses
-1 of the first 4 sx listed below in ! is present:
!-1. Markedly depressed mood, feeling hopeless, self-deprecation
!-2. Marked anxiety, tension, feeling “on edge”
!-3. Suddenly feeling sad or tearful, increased sensitivity to personal rejection
!-4. Persistent and marked irritability, anger, increased interpersonal conflicts
-5. Decreased interest in usual activities
-6. Subjective sense of difficulty in concentration
-7. Lethargy, fatigue or marked lack of energy
-8. Marked change in appetite and cravings for certain foods
-9. Hypersomnia or insomnia
-10. Feeling overwhelmed or out of control
-11. Physical symptoms (mastodynia, H/A, myalgia, bloating, weight gain)
-Disturbance markedly interferes with daily activities (work, school, social life, etc.)
-Disturbance is not merely an exacerbation of another disorder
-All of the above, including symptoms, must be confirmed by prospective daily ratings (symptom diary) during at least 2 consecutive symptomatic cycles
management of PMDD
-tx of PMS
-SSRI (fluoxetine, sertraline are particularly recommended)
-Consider anxiolytic if the patient does not respond
-Oral contraceptives
-Ethinyl estradiol and drospirenone found to be effective in PMDD
-GnRH agonists
-There is no long term study demonstrating the benefit of these agents, which may have significant side effects